Jun 23, 2026 · 12:09 AM
Subscribe
POSTS FROM

Ai

Insilico Medicine signs a $2.5 billion AI drug discovery deal with SK Biopharmaceuticals for neuroimmune disorders
AI ★ FEATURED
Insilico Medicine signs a $2.5 billion AI drug discovery deal with SK Biopharmaceuticals for neuroimmune disorders
Insilico Medicine and SK Biopharmaceuticals announced a $2.5 billion collaboration at BIO 2026 targeting neuroimmune CNS disorders, with just $18 million paid upfront and the rest tied to milestones. The deal structure reveals how pharma is treating AI drug discovery platforms: as high-upside options on unproven pipelines, not proven molecules.
Ron Patel
5 min read
83 views
Featured
Sort by:
Latest Most Read
Showing 2440 articles
1 2 3 271
Most Read in Ai
Follow Startup Fortune on Google News
Follow us on Google News
Topics